Enara Bio

About:

Ervaxx is illuminating the immune interface to develop new cancer therapies.

Website: https://enarabio.com/

Twitter/X: enara_bio

Top Investors: RA Capital Management, Samsara BioCapital, SV Health Investors, The Francis Crick Institute, Pfizer Venture Investments

Description:

Enara Bio is a science-led company targeting the T-cell/cancer cell interface (the “immune synapse”) to develop new targeted cancer immunotherapies designed to treat a broad patient population. Enara Bio focuses on discovering and developing therapeutic cancer vaccines utilizing novel antigens derived from endogenous retroviral (ERV)-related DNA sequences.